Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 2, 2006, Pages 428-434

  Danielsson, Ingela ^a,b   Gasior, Maciej ^a   Stevenson, Glenn W ^d   Folk, John E ^c   Rice, Kenner C ^c   Negus, S Stevens ^d  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Cyberonics Inc   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Convulsion; Delta opioid receptor; EEG; Rhesus monkey; Seizure; SNC80

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONVULSION; ELECTROENCEPHALOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STANDARDIZATION;

ANIMALS; BENZAMIDES; ELECTROENCEPHALOGRAPHY; MACACA MULATTA; MALE; PIPERAZINES; RECEPTORS, OPIOID, DELTA; SEIZURES;

MACACA MULATTA; PRIMATES;

EID: 33845295133     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.09.012     Document Type: Article

References (32)

1. Allen R.M., Granger A.L., and Dykstra L.A. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther 300 (2002) 435-441
2. Bilsky E.J., Calderon S.N., Wang T., Bernstein R.N., Davis P., Hruby V.J., et al. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273 (1995) 359-366
3. Brandt M.R., Negus S.S., Mello N.K., Furness M.S., Zhang X., and Rice K.C. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys. J Pharmacol Exp Ther 290 (1999) 1157-1164
4. Brandt M.R., Furness M.S., Mello N.K., Rice K.C., and Negus S.S. Antinociceptive effects of delta-opioid agonists in rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther 296 (2001) 939-946
5. Brandt M.R., Furness M.S., Rice K.C., Fischer B.D., and Negus S.S. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther 299 (2001) 629-637
6. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology (Berl) 164 (2002) 42-48
7. Broom D.C., Nitsche J.F., Pintar J.E., Rice K.C., Woods J.H., and Traynor J.R. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. J Pharmacol Exp Ther 303 (2002) 723-729
8. Calderon S.N., Rothman R.B., Porreca F., Flippen-Anderson J.L., McNutt R.W., Xu H., et al. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 37 (1994) 2125-2128
9. Casaubon L., Pohlmann-Eden B., Khosravani H., Carlen P.L., and Wennberg R. Video-EEG evidence of lateralized clinical features in primary generalized epilepsy with tonic-clonic seizures. Epileptic Disord 5 (2003) 149-156
10. Chang K.J., Rigdon G.C., Howard J.L., and McNutt R.W. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 267 (1993) 852-857
11. Comer S.D., Hoenicke E.M., Sable A.I., McNutt R.W., Chang K.J., De Costa B.R., et al. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 267 (1993) 888-895
12. Dykstra L.A., Schoenbaum G.M., Yarbrough J., McNutt R., and Chang K.J. A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. J Pharmacol Exp Ther 267 (1993) 875-882
13. Gross G.J., Fryer R.M., Patel H.H., and Schultz J.E.J. Cardioprotection and delta opioid receptors. In: Chang K.J., Porreca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York 451-466
14. Hiller J.M., and Fan L.Q. Laminar distribution of the multiple opioid receptors in the human cerebral cortex. Neurochem Res 21 (1996) 1333-1345
15. Hong E.J., Rice K.C., Calderon S.N., Woods J.H., and Traynor J.R. Convulsive behavior of nonpeptide ∂-opioid ligands: comparison of SNC80 and BW373U86 in mice. Analgesia 3 (1998) 269-276
16. Jutkiewicz E.M., and Woods J.H. Antidepressant-like effects of delta opioid receptor agonists. In: Chang K.J., Porreca F., and Woods J.H. (Eds). The delta receptor (2004), Marcel Dekker, New York 355-371
17. Jutkiewicz E.M., Eller E.B., Folk J.E., Rice K.C., Traynor J.R., and Woods J.H. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. J Pharmacol Exp Ther 309 (2004) 173-181
18. Jutkiewicz E.M., Baladi M.G., Folk J.E., Rice K.C., and Woods J.H. The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. J Pharmacol Exp Ther 317 (2006) 1337-1348
19. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 15 (1995) 615-635
20. Lord J.A., Waterfield A.A., Hughes J., and Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature 267 (1977) 495-499
21. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7 (1987) 2445-2464
22. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci 11 (1988) 308-314
23. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., and Gilbert P.E. The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197 (1976) 517-532
24. Mathieu-Kia A.M., Fan L.Q., Kreek M.J., Simon E.J., and Hiller J.M. Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. Brain Res 893 (2001) 121-134
25. Mennicken F., Zhang J., Hoffert C., Ahmad S., Beaudet A., and O'Donnell D. Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465 (2003) 349-360
26. Moraes M.F., Chavali M., Mishra P.K., Jobe P.C., and Garcia-Cairasco N. A comprehensive electrographic and behavioral analysis of generalized tonic-clonic seizures of GEPR-9s. Brain Res 1033 (2005) 1-12
27. Negus S.S., Butelman E.R., Chang K.J., DeCosta B., Winger G., and Woods J.H. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270 (1994) 1025-1034
28. Negus S.S., Gatch M.B., Mello N.K., Zhang X., and Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286 (1998) 362-375
29. Negus S.S., Vanderah T.W., Brandt M.R., Bilsky E.J., Becerra L., and Borsook D. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 319 (2006) 507-514
30. Ossipov M.H., Lai J., Vanderah T., and Porecca F. The delta opioid receptor subtypes and pain modulation. In: Chang K.J., Porreca F., and Woods J.H. (Eds). The delta receptor (2004), Marcel Dekker, New York 297-329
31. Peckys D., and Landwehrmeyer G.B. Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience 88 (1999) 1093-1135
32. Weber R.J., and Gomez-Flores R. Delta opioids and immune function. In: Chang K.J., Porreca F., and Woods J.H. (Eds). The delta receptor (2004), Marcel Dekker, New York 383-399